2021
Fludrocortisone for orthostatic hypotension
Search citation statements
Paper Sections
Select...
38
6
1
0
Citation Types
0
22
0
2
Year Published
2021
2026
Publication Types
Select...
39
3
2
1
Relationship
0
45
Authors
Journals
Cited by 43 publications
(24 citation statements)
References 119 publications
0
22
0
2
“…Although it is hard to derive publication for new associations, we can instead obtain confirmation for some drug-disease associations. Thus, by raising association of the drug of fludrocortisone and the disease of hypertension from label transfering, we have found a paper of Veazie et al 31 on this association. The disease of orthostatic hypotension is an overstated drop in blood pressure while standing.…”
Section: Discussionmentioning
confidence: 85%
“…Although it is hard to derive publication for new associations, we can instead obtain confirmation for some drug-disease associations. Thus, by raising association of the drug of fludrocortisone and the disease of hypertension from label transfering, we have found a paper of Veazie et al 31 on this association. The disease of orthostatic hypotension is an overstated drop in blood pressure while standing.…”
Section: Discussionmentioning
confidence: 85%
“…Though data from RCTs is considered more robust, the RCTs included in this meta-analysis have included small numbers of patients belonging to particular phenotypes, hence it can be argued that real world data could fare better in this condition. As such non-inclusion of non RCTs in this study may be perceived as a limitation and this certainly is the case for medications such as fludrocortisone, as shown in this recent systematic review (39). It is prudent to re-visit and possibly study long term effects of the older approved medications prospectively in phase 4 trials such as NCT04128137 and trials such as CONFORM-OH (40) and/or in registries.…”
Section: Discussionmentioning
confidence: 99%
“…However, a Cochrane review found that there is uncertain evidence for fludrocortisone in OH management, including in PD. 22 Therefore, this study’s method is significantly limited, as active controls need to have previously demonstrated efficacy in order to demonstrate trial sensitivity. 22 The Okamoto et al , 8 Schreglmann et al , 15 Singer et al , 10 Shibao et al 13 are cross-over trials.…”
Section: Discussionmentioning
confidence: 99%
“… 22 Therefore, this study’s method is significantly limited, as active controls need to have previously demonstrated efficacy in order to demonstrate trial sensitivity. 22 The Okamoto et al , 8 Schreglmann et al , 15 Singer et al , 10 Shibao et al 13 are cross-over trials. While they offer certain advantages such as increasing statistical power and reducing confounding variables, the interpretation of these trials must be undertaken with caution.…”
Section: Discussionmentioning
confidence: 99%
